The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 26, 2016
Filed:
Aug. 08, 2012
Applicants:
Deborah Ricci, Ringoes, NJ (US);
Weimin LI, Radnor, PA (US);
Erin Devay Henitz, Flemington, NJ (US);
Inventors:
Deborah Ricci, Ringoes, NJ (US);
Weimin Li, Radnor, PA (US);
Erin DeVay Henitz, Flemington, NJ (US);
Assignee:
Janssen Pharmaceutica NV, Beerse, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); A61K 39/395 (2006.01); C12Q 1/68 (2006.01); A61K 31/196 (2006.01); A61K 31/573 (2006.01); A61K 31/69 (2006.01); G01N 33/92 (2006.01); A61K 31/19 (2006.01); A61K 31/198 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); A61K 31/19 (2013.01); A61K 31/196 (2013.01); A61K 31/198 (2013.01); A61K 31/573 (2013.01); A61K 31/69 (2013.01); A61K 39/39558 (2013.01); G01N 33/57407 (2013.01); G01N 33/92 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention provides methods of predicting a response to a cancer treatment by determining CD68 level or PSMB1 (P11A) polymorphism in a biological sample and the presence or quantity of a second biomarker in the patient. The invention also provides kits and methods for treating cancer.